Uterotonic agents for preventing postpartum haemorrhage:a network meta-analysis (Protocol)

This is the protocol for a review and there is no abstract. The objectives are as follows:We aim to assess the clinical effectiveness and side-effect profile of uterotonic drugs to prevent PPH, and to generate a clinically useful ranking of available uterotonics according to their effectiveness and side-effects. We will explore the effects according to various key prognostic and treatment factors. The population of interest is women following a vaginal birth or a caesarean section in the hospital or the community setting. All uterotonic drugs considered by theWHO are eligible and the outcomes include blood loss-related outcomes and side-effects.